isomethyleugenol has been researched along with Atherosclerotic Parkinsonism in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, JC; Moon, MH; Yang, JS | 1 |
| Beach, JW; Collins, MA; Gearhart, DA; Hwang, YI; Neafsey, EJ; Schwarz, J; Storch, A | 1 |
| Ramsden, DB; Williams, AC | 1 |
| Hattori, T; Kondo, T; Mizuno, Y; Nakagawa-Hattori, Y | 1 |
| Charlton, CG; Lamango, NS | 1 |
| Cotzias, GC | 1 |
1 review(s) available for isomethyleugenol and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Autotoxicity, methylation and a road to the prevention of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Humans; Methylation; Niacinamide; Parkinson Disease; Parkinson Disease, Secondary; Risk Factors; S-Adenosylmethionine | 2005 |
5 other study(ies) available for isomethyleugenol and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Simultaneous Relative Quantification of Various Polyglycerophospholipids with Isotope-Labeled Methylation by Nanoflow Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectrometry.
Topics: 1-Methyl-4-phenylpyridinium; Cell Line, Tumor; Chromatography, High Pressure Liquid; Deuterium; Humans; Isotope Labeling; Methylation; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylglycerols; Rotenone; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2019 |
Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: relationship to transporter-dependent uptake.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Carbolines; Cell Line; Cell Survival; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Harmaline; Harmine; Humans; Inhibitory Concentration 50; Kidney; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Methylation; Nerve Tissue Proteins; Parkinson Disease, Secondary; Piperazines | 2004 |
S-methylation in Parkinson's disease.
Topics: Aged; Erythrocyte Membrane; Female; Humans; Male; Methylation; Methyltransferases; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Reference Values; Sulfhydryl Compounds | 1995 |
Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats.
Topics: Amphetamine; Animals; Central Nervous System Stimulants; Chromatography, Gel; Cysteine; Freeze Drying; Male; Methylation; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; S-Adenosylmethionine; Stereotyped Behavior; Sympathectomy, Chemical; Tremor | 2000 |
Levodopa in the treatment of Parkinsonism.
Topics: Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Dihydroxyphenylalanine; Dopamine; Esters; Humans; Hydrazines; Manganese Poisoning; Methylation; Methyldopa; Mice; Movement; Parkinson Disease; Parkinson Disease, Secondary; Phenylacetates | 1971 |